By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

MolecularMD 

2611 SW 3rd Avenue

Portland  Oregon  97201  U.S.A.
Phone: 888-663-7382 Fax: 503-459-4976


SEARCH JOBS


Industry
Diagnostics






Company News
MolecularMD Develops Notch1 Next Generation Sequencing Test To Support Clinical Development For OncoMed Pharmaceuticals, Inc. (OMED)'s Anti-Notch1 Antibody, OMP-52M51 6/12/2014 10:08:39 AM
MolecularMD Receives CLIA Certification For Its Second Next Generation Sequencing Laboratory 4/7/2014 10:37:31 AM
MolecularMD Launches NanoString Platform For Multiplexed Digital Evaluation Of Gene Expression And Copy Number Variation In Clinical Specimens 3/6/2014 9:19:33 AM
MolecularMD To Develop Highly Sensitive Companion Diagnostic Test To Support CML Treatment Free Remission Clinical Trials 2/19/2014 10:16:10 AM
MolecularMD Announces Presentations at Upcoming American Society of Hematology Annual Meeting 12/5/2013 9:52:01 AM
Personal Genome Diagnostics and MolecularMD Collaborate to Provide Advanced Genomic Testing Services to Cancer Drug Developers 10/25/2013 10:01:42 AM
MolecularMD Obtains License to Commercialize Predictive Diagnostic Based on Actionable Biomarker, DDR2, for Uses in Lung Cancer and Targeted Kinase Therapy 7/29/2013 9:42:00 AM
MolecularMD Obtains Exclusive License to Uses of FGFR2 Activating Mutations in Endometrial Cancer 5/30/2013 11:02:09 AM
MolecularMD Offers Testing Services for Determining LKB1 Mutation and Expression Status 4/9/2013 12:18:31 PM
MolecularMD Announces Launch of Next Generation Sequencing Services for Oncology Drug Development 4/4/2013 9:25:56 AM
123
//-->